Antacid Oral Suspension Recalled Nationwide for Microbial Contamination
Plastikon Healthcare LLC is recalling an antacid oral suspension distributed nationwide due to microbial contamination. Affected lots 20051A (exp. Aug. 2022) and 20088A (exp. Sep. 2022) should not be used.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall carries an FDA Class I designation, the most serious classification, indicating a serious potential hazard. The rubric requires a minimum score of 4 for FDA Class I recalls. No illnesses or deaths have been reported in the source material.
Plain-English summary
Plastikon Healthcare LLC is recalling Magnesium Hydroxide 2400 mg, Aluminum Hydroxide 2400 mg, and Simethicone 240 mg oral suspension in 30 mL cups labeled for institutional use only. The product was distributed nationwide across the United States, with approximately 43,200 cups in circulation.
The recall is due to microbial contamination in the non-sterile formulation. The affected lots are 20051A (expiration August 2022) and 20088A (expiration September 2022).
Institutions and individuals who have received this product should stop using it immediately. Contact your healthcare provider or pharmacist for guidance on alternative treatments. Healthcare facilities should quarantine affected inventory and contact their distributor for return instructions and replacement product.
The recalled product
- Product
- Magnesium Hydroxide 2400 mg, Aluminum Hydroxide 2400 mg, Simethicone 240 mg MAX, per 30 mL Oral Suspension, 30 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC
- Manufacturer
- Plastikon Healthcare LLC
- Category
- Drug — Antacid Oral Suspension
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 20051A
- EXP Aug. 2022
- 20088A
- EXP Sep. 2022.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27